Feb, 2016

U.S.A.
News / Corporate
Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries
Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") announced today that it has successfully completed, through its indirect wholly-owned subsidiary Laurel...
Read More

Jan, 2016

U.S.A.
News / Corporate
Astellas Announces Financial Results for Q3 FY2015
Please click here for more details. About Astellas Astellas is a pharmaceutical company dedicated to improving the health of people around the world through provision of innovative and reliable...
Read More
U.S.A.
News / Corporate
Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics
Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") and Ocata Therapeutics, Inc. (NASDAQ: OCAT, President and CEO: Paul Wotton, "Ocata") today announced that...
Read More

Dec, 2015

U.S.A.
News / Corporate
Astellas to Present at J.P. Morgan Healthcare Conference
Astellas Pharma today announced that the company's President and CEO Yoshihiko Hatanaka will present at the 34th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12, 2016 in San...
Read More

Nov, 2015

U.S.A.
News / Corporate
New Survey Examines How and to What Extent Americans Talk About Going to the Bathroom
Baltimore, MD, November 23, 2015—During Bladder Health Month, The American Urological Association (AUA) and Urology Care Foundation, in collaboration with Astellas, unveiled results from a...
Read More